在基于CRISPR的转录激活系统中激活剂表达的细胞毒性
Aakaanksha Maddineni1, Ziyan Liang1, Shreya Jambardi1
1Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
bioRxiv : the preprint server for biology
|October 10, 2024
概括
常见的基于CRISPR的转录激活系统 (CRISPRa) 显示出显著的细胞毒性. 这种与强有力的激活剂相关的细胞毒性限制了CRISPRa.
科学领域:
- 分子生物学分子生物学
- 基因编辑技术的技术
- 细胞毒理学细胞毒理学
背景情况:
- 基于CRISPR的转录激活 (CRISPRa) 是调节基因表达的强大工具.
- 现有的CRISPRa系统,特别是协同激活调解器 (SAM) 系统,在研究中得到广泛使用.
- 关于CRISPRa工具的安全性和可靠性的担忧正在出现.
研究的目的:
- 为了研究常用的CRISPRa系统的细胞毒性.
- 评估表达转录激活域对细胞活性的影响.
- 确定当前广泛应用的CRISPRa技术的潜在局限性.
主要方法:
- 表达p65和HSF1激活域 (ADs) 的CRISPRa载体的评估毒性.
- 将研究扩展到其他ADS和p300乙转移酶核心领域.
- 使用可诱导的lentiviral向量来探索激活器表达窗口.
主要成果:
- 已发表的和新的CRISPRa载体显示出显著的细胞毒性.
- 强大的转录激活剂的表达降低了lentiviral标位,并导致细胞死亡.
- 在没有可测量的毒性的情况下,没有确定基于SAM的CRISPRa的安全窗口.
结论:
- 包括SAM在内的当前CRISPRa系统的细胞毒性阻碍了它们的广泛使用.
- 毒性引入了选择瓶,可能会损害基因查结果.
- 未来的CRISPR开发必须平衡激活效率与降低激活剂毒性.
相关概念视频
CRISPR
49.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.7K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Homologous Recombination
50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K


